Results 261 to 270 of about 580,532 (393)

Obscurin deficiency leads to compensated dilated cardiomyopathy and increased arrhythmias. [PDF]

J Gen Physiol
Pioner JM, Pierantozzi E, Coppini R, Rubino EM, Biasci V, Vitale G, Laurino A, Santini L, Scardigli M, Randazzo D, Olianti C, Serano M, Rossi D, Tesi C, Cerbai E, Lange S, Reggiani C, Sacconi L, Poggesi C, Ferrantini C, Sorrentino V.   +20 more
europepmc   +1 more source

Dilated Cardiomyopathy with Special Reference to Humoral Immunity.

, 1992
Shinji Fukuta, Toshiko Yoshinaga, Katsutoshi Yamakawa, Y Kimura, Reizo Kusukawa   +4 more
openalex   +2 more sources

A Clinical Study of Primary Dilated Cardiomyopathy [PDF]

, 1991
Gil Ja Shin
openalex   +1 more source

Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure

European Journal of Heart Failure, EarlyView.
Heart failure (HF) with supranormal ejection fraction (HFsnEF) is an unnoticed but emerging entity in HF. This study showed that HFsnEF carries a similarly increased cardiovascular risk as HF with reduced ejection fraction (HFrEF) and distinct structural and proteomic characteristics from HFrEF, warranting a further comprehensive understanding and ...
Yasuhiko Sakata, Kotaro Nochioka, Satoshi Yasuda, Koichi Ishida, Takashi Shiroto, Jun Takahashi, Shintaro Kasahara, Ruri Abe, Shinsuke Yamanaka, Takahide Fujihashi, Hideka Hayashi, Shintaro Kato, Katsunori Horii, Kanako Teramoto, Tsutomu Tomita, Satoshi Miyata, Koichiro Sugimura, Iwao Waga, Masao Nagasaki, Hiroaki Shimokawa   +19 more
wiley   +1 more source

Environmental Risk Factors Are Associated With the Natural History of Familial Dilated Cardiomyopathy. [PDF]

J Am Heart Assoc
Peters SA, Wright L, Yao J, McCall L, Thompson T, Thompson B, Johnson R, Huynh Q, Santiago CF, Trainer A, Perrin M, James P, Zentner D, Kalman J, Marwick TH, Fatkin D.   +15 more
europepmc   +1 more source

Effects of long-term .BETA.-blockade (metoprolol) therapy in patients with dilated cardiomyopathy.

, 1991
YOSHIYUKI YOKOTA, Hideki Nomura, Hiroya Kawai, Yasuhiro Tsumura, Yoshio Takéuchi, Hiroaki Kurozumi, Akira Takarada, Hisashi Fukuzaki   +7 more
openalex   +2 more sources

Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future

Circulation, 2017
B. Halliday, J. Cleland, J. Goldberger, S. Prasad   +3 more
semanticscholar   +1 more source

Cancer therapy‐related cardiotoxicity is associated with distinct alterations of the myocardial lipidome

European Journal of Heart Failure, EarlyView.
Lipidome changes in anthracycline‐induced cardiotoxicity (AIC). Aims Anthracyclines are key components of various chemotherapy regimens, but their clinical utility is limited by severe cardiotoxic side effects. Previous studies have suggested that anthracycline‐induced cardiotoxicity (AIC) may be driven by alterations in myocardial lipid metabolism ...
Vera M. Braun, Anna Foryst‐Ludwig, Ulf Landmesser, István Baczkó, Hendrik Milting, Ulrich Kintscher, Niklas Beyhoff   +6 more
wiley   +1 more source

Pheochromocytoma-Induced Reversible Dilated Cardiomyopathy: A Case Report and Literature Review. [PDF]

Clin Case Rep
Afra F, Rahimi M, Hemmatabadi M, Mohammadi S, Shirzad N.   +4 more
europepmc   +1 more source

Genetic Analysis of Dilated Cardiomyopathy. HLA and immunoglobulin genes may confer susceptibility.

, 1992
Hirofumi Nishi, Akinori Kimura, Shinji Fukuta, Reizo Kusukawa, Keishiro Kawamura, Yasuharu Nimura, Makoto Nagano, Hisakazu Yasuda, Chuichi Kawai, Tsuneaki Sugimoto, Ryozo Okada, Yoshio Yazaki, Hiromitsu Tanaka, Kenichi Harumi, Yoshinori Koga, Takehiko Sasazuki, Hironori Toshima   +16 more
openalex   +2 more sources